rel-((3R,4R)-4-Aminotetrahydrofuran-3-yl)methanol hydrochloride, 97%, 1g

tert-butyl 3-(piperidin-4-yloxy)pyrrolidine-1-carboxylate, 95.0%, 250mg

2-{[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]amino}acetohydrazide, 1g

5-Chloro-2-nitroaniline, 97.0%, 5g

4-Bromo-5-methylindoline-2,3-dione, 95.0%, 5g

Óxido de bario en polvo 99,5% -100 malla 10 g

5F-203, 25mg

(4-Methoxy-benzyl)-methyl-piperidin-4-yl-amine hydrochloride, 95.0%, 250mg

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline, 95.0%, 100mg

2-(2-Aminoetilamino)etanol, min 98%, para síntesis, 1 L, envase de vidrio

3-Amino-3-methyloxetane hydrochloride, 97.0%, 1g

(S)-Methyl 2,3-diaminopropanoate dihydrochloride, 97.0%, 5g

4-Chloro-N-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)benzamide, 98.0%, 250mg